Opus Genetics (IRD) Tax Rate (2022 - 2023)
Opus Genetics (IRD) reported Tax Rate of 0.04% for Q4 2023, down 88.0% year-over-year from 0.35% in Q4 2022, and down 83.4% on a QoQ basis from 0.25% in Q3 2023.
Opus Genetics (IRD) has 2 years of Tax Rate data on file, last reported at 0.04% in Q4 2023.
- Quarterly Tax Rate fell 88.0% year-over-year to 0.04% in Q4 2023, while the trailing twelve-month figure through Sep 2024 was 0.01% (down 112.0% YoY) and the FY2023 annual result came in at 0.12%, down 185.0% from the prior year.
- Tax Rate retreated to 0.04% in Q4 2023 per IRD's latest filing, from 0.25% in the prior quarter.
- Across five years, Tax Rate topped out at 0.92% in Q4 2022 and bottomed at 0.04% in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 57.14 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 5.61 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.68 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -6.79 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.51 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7.07 |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 0.04 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.25 |
| Sep 30, 2023 | 0.25 |
| Dec 31, 2022 | 0.92 |
| Dec 31, 2022 | 0.92 |